X
Archive by tag: GoodwinReturn

Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation

We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....By: Goodwin
Read More
Goodwin | Jul 14,2020 |

Financial Services Weekly Roundup: OCC Adds “Madden Fix” To Its Playbook

In This Issue. The Office of the Comptroller of the Currency (OCC) finalized its “Madden fix,” establishing a rule that codifies the “valid when made” principle for nationally chartered banks; the Securities and Exchange Commission (SEC) reversed a...By: Goodwin
Read More
Goodwin | Jun 05,2020 |

SEC Adopts Amendments to Rules Governing Financial Disclosures on Material Acquisitions and Dispositions of Businesses

In an effort to reduce the complexity and compliance costs of financial disclosures for significant acquisitions or dispositions of businesses, the SEC has adopted amendments to the applicable rules, reducing the scope of certain required financial...By: Goodwin
Read More
Goodwin | Jun 05,2020 |

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...By: Goodwin
Read More
Goodwin | May 14,2020 |

Chinese Investments Into India

On April 17, 2020, India announced a change to its foreign investment policy under which investments by “an entity of a country, which shares a land border with India or where the beneficial owner of an investment into India is situated in or is a...By: Goodwin
Read More
Goodwin | Apr 22,2020 |

Satisfying “Commercially Reasonable Efforts” / “Best Efforts” Clauses In Today’s Environment

Over the past several weeks, the novel coronavirus (COVID-19) has upended the marketplace and imposed upon industries, companies, and their workforce new and often unanticipated challenges and delays. Many deal and commercial contracts contain...By: Goodwin
Read More
Goodwin | Apr 03,2020 |

Competitor Collaborations in the U.S. During COVID-19

U.S. companies may see opportunities to increase collaborations amongst one another during the current pandemic, but should be aware that they are still subject to the antitrust laws. Fortunately, Tuesday, March 24th, the Federal Trade Commission...By: Goodwin
Read More
Goodwin | Mar 27,2020 |

COVID-19: Delays May Affect Construction Project Schedules and Budgets

On March 16, Boston mayor Martin Walsh issued an order halting all construction projects in the city, citing concerns with worker safety and a need to slow the spread of COVID-19. While a similar order has not yet been issued in Connecticut, owners,...By: Shipman & Goodwin LLP
Read More
Shipman & Goodwin LLP | Mar 20,2020 |

HSR Filings in Light of COVID-19

In light of the coronavirus pandemic, Friday, the Federal Trade Commission (“FTC”) and the Antitrust Division of the Department of Justice (“DOJ,” and collectively the “Antitrust Agencies”) announced modified procedures related to Hart-Scott-Rodino...By: Goodwin
Read More
Goodwin | Mar 16,2020 |

All the Ways Startups and New Employers Can Get Into Trouble

Last night, I had the opportunity (again) to sit on a panel discussion sponsored by the Accelerator for Biosciences in Connecticut (ABCT) to talk about operational challenges for new companies and the issues associated with hiring. ABCT is one of...By: Shipman & Goodwin LLP
Read More
Shipman & Goodwin LLP | Mar 06,2020 |
Page 2 of 13 [2]